News
Top Questions About Undergoing IVF and GLP-1 Medications
The decision to pursue in vitro fertilization (IVF) is often filled with hope, planning, and many important questions. For some patients, especially those managing weight or metabolic conditions, the rise of GLP-1 medications (like semaglutide or tirzepatide) adds another layer of considerations. Understanding how IVF and GLP-1s intersect can help patients feel more prepared and empowered as they move forward.
In this guide, we’ll cover the most common questions patients ask about IVF, as well as the top questions about undergoing IVF and GLP-1 medications before and during fertility treatment.
Top Questions About IVF
1. How long does the IVF process take?
IVF typically spans 6–8 weeks per cycle, from ovarian stimulation to egg retrieval, fertilization, and embryo transfer. However, the timeline can vary based on your individual treatment plan.
2. What are the chances of success?
Success rates depend on age, egg and sperm quality, uterine health, and clinic experience. On average, women under 35 have higher success rates, while rates decline with age.
3. Is IVF painful?
Most patients describe IVF as uncomfortable rather than painful. Hormone injections can cause bloating and mood changes, while egg retrieval is performed under sedation for comfort.
4. What lifestyle changes can improve IVF success?
A balanced diet, regular exercise, managing stress, limiting alcohol, and avoiding smoking can all help. Some patients also discuss GLP-1 medications with their doctor as part of weight optimization before IVF.
5. How many embryos should be transferred?
The decision depends on age, embryo quality, and medical history. Clinics often recommend one embryo transfer to reduce risks of multiples while maintaining strong pregnancy outcomes.
Top Questions About GLP-1 Medications and Fertility
GLP-1 medications like Ozempic®, Wegovy®, and Mounjaro™ are increasingly popular for weight management and metabolic health. If you’re considering IVF, here are the most common questions patients ask:
1. Can I take GLP-1 medications while trying to conceive?
Current medical guidance recommends discontinuing GLP-1 medications prior to conception. These drugs have not been proven safe during pregnancy, and most providers advise stopping at least two months before attempting conception.
2. Do GLP-1s affect fertility?
There’s no evidence that GLP-1s harm fertility. In fact, for some patients with PCOS or obesity, weight reduction through GLP-1s may help restore more regular cycles and improve reproductive outcomes.
3. Can GLP-1 medications improve IVF success rates?
Indirectly, yes. Achieving a healthier weight and metabolic profile can improve egg quality, implantation rates, and overall IVF success. However, these benefits must be balanced with the need to discontinue the drug before pregnancy.
4. What happens if I get pregnant while on GLP-1s?
If pregnancy occurs while taking a GLP-1, it’s important to stop the medication and notify your doctor immediately. More research is needed, but current data suggest caution due to unknown effects on fetal development.
5. When can I resume GLP-1 medications after IVF or pregnancy?
GLP-1s are not recommended while pregnant or breastfeeding. Many patients restart them postpartum, after finishing breastfeeding, as part of long-term weight management.
Key Takeaways
-
IVF comes with a series of emotional, physical, and logistical questions, but preparing ahead can reduce stress.
-
GLP-1 medications may support metabolic health and weight management, but should be stopped before pregnancy.
-
Always work closely with your fertility specialist and prescribing provider to coordinate care between IVF and GLP-1 use.
Deciding to pursue IVF is a courageous step. For patients also managing weight and metabolic health, GLP-1 medications can play a role in the journey but timing, safety, and coordination with your fertility team are essential. By asking the right questions and staying informed, you give yourself the best chance for success.